Ryan R Skehan

The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.

K. Brown, Lingbao Ai, B. Demircan, 2008, Carcinogenesis.

Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NFκB) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression*

K. Brown, Lingbao Ai, J. Saydi, 2012, The Journal of Biological Chemistry.

The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.

K. Brown, Lingbao Ai, B. Demircan, 2008, Carcinogenesis.

Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NFκB) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression*

K. Brown, Lingbao Ai, J. Saydi, 2012, Journal of Biological Chemistry.